Because Fah−/− rats develop cirrhosis after NTBC withdrawal and permit the extensive repopulation of transplanted cells, it would be worth assessing the therapeutic efficacy of different types of cells, including hepatocytes, on liver cirrhosis in Fah−/− rats. The gene discussed is FAH; the disease is cirrhosis of liver.